Literature DB >> 29156009

Discovering cancer vulnerabilities using high-throughput micro-RNA screening.

Iva Nikolic1,2,3, Benjamin Elsworth1,2, Eoin Dodson1,2, Sunny Z Wu1,2, Cathryn M Gould1,3, Pieter Mestdagh4,5, Glenn M Marshall6, Lisa G Horvath1,7,8, Kaylene J Simpson3,9, Alexander Swarbrick1,2.   

Abstract

Micro-RNAs (miRNAs) are potent regulators of gene expression and cellular phenotype. Each miRNA has the potential to target hundreds of transcripts within the cell thus controlling fundamental cellular processes such as survival and proliferation. Here, we exploit this important feature of miRNA networks to discover vulnerabilities in cancer phenotype, and map miRNA-target relationships across different cancer types. More specifically, we report the results of a functional genomics screen of 1280 miRNA mimics and inhibitors in eight cancer cell lines, and its presentation in a sophisticated interactive data portal. This resource represents the most comprehensive survey of miRNA function in oncology, incorporating breast cancer, prostate cancer and neuroblastoma. A user-friendly web portal couples this experimental data with multiple tools for miRNA target prediction, pathway enrichment analysis and visualization. In addition, the database integrates publicly available gene expression and perturbation data enabling tailored and context-specific analysis of miRNA function in a particular disease. As a proof-of-principle, we use the database and its innovative features to uncover novel determinants of the neuroblastoma malignant phenotype.
© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29156009      PMCID: PMC5728403          DOI: 10.1093/nar/gkx1072

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  46 in total

1.  A skin microRNA promotes differentiation by repressing 'stemness'.

Authors:  Rui Yi; Matthew N Poy; Markus Stoffel; Elaine Fuchs
Journal:  Nature       Date:  2008-03-02       Impact factor: 49.962

2.  Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.

Authors:  Jan J Molenaar; Jan Koster; Danny A Zwijnenburg; Peter van Sluis; Linda J Valentijn; Ida van der Ploeg; Mohamed Hamdi; Johan van Nes; Bart A Westerman; Jennemiek van Arkel; Marli E Ebus; Franciska Haneveld; Arjan Lakeman; Linda Schild; Piet Molenaar; Peter Stroeken; Max M van Noesel; Ingrid Ora; Evan E Santo; Huib N Caron; Ellen M Westerhout; Rogier Versteeg
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

3.  ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin.

Authors:  Abbas Agaimy; Katharina Erlenbach-Wünsch; Björn Konukiewitz; Anja M Schmitt; Ralf J Rieker; Michael Vieth; Franklin Kiesewetter; Arndt Hartmann; Giuseppe Zamboni; Aurel Perren; Günter Klöppel
Journal:  Mod Pathol       Date:  2013-03-15       Impact factor: 7.842

4.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

5.  starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.

Authors:  Jian-Hua Yang; Jun-Hao Li; Peng Shao; Hui Zhou; Yue-Qin Chen; Liang-Hu Qu
Journal:  Nucleic Acids Res       Date:  2010-10-30       Impact factor: 16.971

6.  MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells.

Authors:  Gianluca Turcatel; Nicole Rubin; Ahmed El-Hashash; David Warburton
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

7.  Oasis: online analysis of small RNA deep sequencing data.

Authors:  Vincenzo Capece; Julio C Garcia Vizcaino; Ramon Vidal; Raza-Ur Rahman; Tonatiuh Pena Centeno; Orr Shomroni; Irantzu Suberviola; Andre Fischer; Stefan Bonn
Journal:  Bioinformatics       Date:  2015-02-19       Impact factor: 6.937

8.  Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.

Authors:  Wataru Nakata; Motohide Uemura; Mototaka Sato; Kazutoshi Fujita; Kentaro Jingushi; Yuko Ueda; Kaori Kitae; Kazutake Tsujikawa; Norio Nonomura
Journal:  Oncotarget       Date:  2015-08-28

9.  Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.

Authors:  Haruo Nakano; Yoji Yamada; Tatsuya Miyazawa; Tetsuo Yoshida
Journal:  Int J Oncol       Date:  2013-04-15       Impact factor: 5.650

10.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.

Authors:  Jun-Hao Li; Shun Liu; Hui Zhou; Liang-Hu Qu; Jian-Hua Yang
Journal:  Nucleic Acids Res       Date:  2013-12-01       Impact factor: 16.971

View more
  7 in total

1.  miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.

Authors:  Holly Holliday; Jessica Yang; Eoin Dodson; Iva Nikolic; Alvin Kamili; Madeleine Wheatley; Niantao Deng; Sarah Alexandrou; Thomas P Davis; Maria Kavallaris; C Elizabeth Caldon; Joshua McCarroll; Katleen De Preter; Pieter Mestdagh; Glenn M Marshall; Kaylene J Simpson; Jamie Fletcher; Alexander Swarbrick
Journal:  Mol Ther       Date:  2022-01-05       Impact factor: 11.454

2.  Overexpression of miR-328-5p influences cell growth and migration to promote NSCLC progression by targeting LOXL4.

Authors:  Yanzhao Ji; Yanting You; Yifen Wu; Min Wang; Qiuxing He; Xinghong Zhou; Liqian Chen; Xiaomin Sun; Yanyan Liu; Xiuqiong Fu; Hiu Yee Kwan; Qiang Zuo; Ren Luo; Xiaoshan Zhao
Journal:  Ann Transl Med       Date:  2022-03

3.  Systematic assessment of microRNAs associated with lung cancer and physical exercise.

Authors:  Yang Liu; Libo He; Wang Wang
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 4.  MicroRNA-Regulated Gene Delivery Systems for Research and Therapeutic Purposes.

Authors:  Bijay Dhungel; Charmaine A Ramlogan-Steel; Jason C Steel
Journal:  Molecules       Date:  2018-06-21       Impact factor: 4.411

5.  MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer.

Authors:  Hui-Ming Lin; Iva Nikolic; Jessica Yang; Lesley Castillo; Niantao Deng; Chia-Ling Chan; Nicole K Yeung; Eoin Dodson; Benjamin Elsworth; Calan Spielman; Brian Y Lee; Zoe Boyer; Kaylene J Simpson; Roger J Daly; Lisa G Horvath; Alexander Swarbrick
Journal:  Sci Rep       Date:  2018-05-18       Impact factor: 4.379

6.  Establishment and characterization of a GES-1 human gastric epithelial cell line stably expressing miR-23a.

Authors:  Li Chen; Yan Gao; Lihua Zhu; Hongjiang Song; Linlin Zhao; Aihua Liu; Guangling Zhang; Guoyou Shi
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

7.  Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy.

Authors:  Bijaya Malla; Daniel M Aebersold; Alan Dal Pra
Journal:  J Transl Med       Date:  2018-08-13       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.